Parkinsonism Occurs Frequently in Chronic Traumatic Encephalopathy

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, July 16, 2024 -- Multiple substantia nigra (SN) pathologies are associated with parkinsonism, according to a study published online July 15 in JAMA Neurology.

Jason W. Adams, Ph.D., from the Boston University Alzheimer's Disease and CTE Center, and colleagues examined the frequency of parkinsonism in individuals with chronic traumatic encephalopathy (CTE) in a cross-sectional study.

The researchers found that parkinsonism occurred frequently in individuals with CTE, occurring in 24.7 percent of 481 male brain donors with neuropathologically diagnosed CTE. Compared with those without parkinsonism, those with parkinsonism had a more severe CTE stage (e.g., stage IV: 29.4 versus 10.8 percent) and nigral pathology (neurofibrillary tangles [NFTs]: 42.7 versus 29.9 percent; neuronal loss: 52.1 versus 17.1 percent; Lewy bodies [LBs]: 24.1 versus 5.8 percent). Associations were seen for years of contact sports participation with substantia nigra (SN) NFTs and neuronal loss. Associations were also seen for nigral neuronal loss and LBs with parkinsonism. SN neuronal loss was associated with SN LBs, SN NFTs, and arteriolosclerosis. A regression analysis demonstrated that SN NFTs and neuronal loss mediated the association between years of play and parkinsonism in the context of CTE among American football players.

"The findings suggest that extensive repetitive head injury is associated with parkinsonism through increased tau pathology and neuronal loss, even in the absence of Lewy pathology," the authors write.

Several authors disclosed ties to the biopharmaceutical and sports industries.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-17 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords